Dec 12, 2018 | featured, newsroom
INDIANAPOLIS (December 12, 2018) — BioCrossroads announced today that after 14 years as president and CEO, David L. Johnson will leave the organization, effective December 31, 2018, to assume his responsibilities as president and CEO of the Central Indiana...Dec 4, 2018 | featured, newsroom
INDIANAPOLIS, Ind., December 4, 2018 — BioCrossroads announced today that the Richard M. Fairbanks Foundation has made a grant of $1.48 million to the organization to continue to advance the strength and opportunities of several collaborative and educational...Oct 10, 2018 | featured, newsroom
BioCrossroads seed funds have funded 24 Indiana start-ups since inception Indianapolis, October 10, 2018 — BioCrossroads today announced the formation of its $9 million Indiana Seed Fund III at its Indiana Life Sciences Summit. The Indiana Seed Fund III is an...Oct 10, 2018 | featured, newsroom
INDIANAPOLIS, Ind., Oct. 10, 2018 — BioCrossroads Board of Directors named esteemed researcher, educator and entrepreneur Anantha Shekhar, M.D., Ph.D., executive associate dean for research affairs at the Indiana University School of Medicine, recipient of the 2018...Oct 4, 2018 | featured, newsroom
Indiana University, Purdue University and University of Notre Dame drive innovation and see pathways for more funding opportunities INDIANAPOLIS, Oct. 4, 2018 – BioCrossroads, in collaboration with TEConomy Partners, has released a significant follow-up study to the...Sep 27, 2018 | featured, newsroom
INDIANAPOLIS, Ind., Sept. 27, 2018 — BioCrossroads announces the finalists for its life sciences start up business plan competition and its inaugural Indiana Inject Tech Challenge – a digital health competition. Since 2012, the BioCrossroads New Venture Competition...
